1. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ. Campylobacter pyloridis-associated chronic active antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterol 94:33–401988.
2. Graham DY.
Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 6:105–1131991.
3. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol. Clin N Am 22:89–1041993.
4. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Issacson PG.
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175–11761991.
5. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de-Boni M, Issacson PG. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of
Helicobacter pylori. Lancet 342:575–5771993.
6. Cullen DJE, Collins BJ, Christiansen KJ, Epis J, Warren JR, Cullen KJ. Long term risk of peptic ulcer disease in people with H. pylori infection – a community based study. Gastroenterol 104:A60. 1993.
7. Sipponen P, Varis K, Fraki O, Dorri UM, Seppala K, Siurala M. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer patients with or without chronic gastritis: a clinical follow-up study of 454 outpatients. Scand J Gastroenterol 25:996–9731990.
8. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1:1167–11681989.
9. McColl KEL, Fullarton GM, el Nujumi AM, McDonald AM, Brown IL, Hilditch TE. Lowered gastrin and gastric acididty after eradication of Campylobacter pylori in duodenal ulcer. Lancet 2:499–5001989.
10. Levi S, Beardshall K, Swift I, Foulkes W, Playford R, Ghosh P, Calam J. Antral
Helicobacter pylori, hypergastrinemia and duodenal ulcers: effect of eradicating the organism. BMJ 299:1504–15051989.
11. Graham DY, Opekun A, Lew GM, Evans DJ Jr, Klein PD, Evans DG. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 85:394–3981990.
12. Prewett EJ, Smith JT, Nwokolo CU, Hudson M, Sawyerr AM, Pounder RE. Eradiaction of
Helicobacter pylori abolishes 24-hour hypergastrinemia: a prospective study in healthy subjects. Aliment Pharmacol Therp 5:283–2931991.
13. McKoll KE, Fullarton GM, Chittajallu R, el Nujumi AM, McDonald AM, Dahill SW, Hilditch TE. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of
Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 26:339–3461991.
14. Graham DY, Opekun A, Lew GM, Klein PD, Walsh JH.
Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterol 100:1571–15751991.
15. EI-Omar E, Penman I, Dirrian CA, Ardil JES, McColl KEL. Eradicating
Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patientrs with duodenal ulcer. Gut 34:1060–10651993.
16. Peterson WL, Barnett CC, Evans DJ Jr, Feldman M, Carmody T, Richardson C, Walsh J, Graham DY. Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of
Helicobacter pylori. Am J Gastroenterol 88:2038–20431993.
17. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of
Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340:930–9321992.
18. Queiroz DMM, Mendes EN, Rocha GA, Moura SB, Resende LMH, Barbosa AJA, Coelho LGV, Pass MCE, Castro LP, Oliveira CA, Lima GF. Effects of
Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scand J Gastroenterol 28:858–8641993.
19. Kaneko H, Nakada K, Mitsuna T, Uchida K, Furusawa A, Maeda Y, Morise K.
Helicobacter pylori infection induces a decrease in concentrations of human stomach. Dig Dis Sci 37:409–4161992.
20. Sankey EA, Helliwell PA, Dhillon AP. Immunostaining of antral gastrin cells is quantitatively increased in
Helicobacter pylori gastritis. Histopathology 23:970–9771990.
21. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of
Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340:930–9321992.
22. Oderada G, Vaira D, Holton J, Ainley F, Anasaldi N. Amoxycillin and tinidazole for Campylobacter pylori gastritis in children: assessment of serum IgG antibody, pepsinogen I and gastrin levels. Lancet 1:690. 1989.
24. Chittajallu RS, Neuthercut WD, MacDonald AMI, McColl KEL. Effect of increasing
Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentration. Gut 32:21–241991.
25. Nujumi AME, Dorrian CA, Chittajallu RS, Neuthercut WD, McColl KEL. Effect of inhibition of
Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut 32:866–8701991.
26. Sumii M, Sumii K, Tari A, Kawaguchi H, Yamamoto G, Takehara Y, Fukino Y, Kamiyasu T, Hamada M, Tsuda T, Yoshihara M, Haruma K, Kajiyama G. Expression of antral gastrin and somatostatin mRNA in
Helicobacter pylori-infected subjects. Am J Gastroenterol 89:1515–15191994.
27. Odum L, Peterson HD, Andersen IB, Hansen BF, Rehfeld JF. Gastrin and somatostatin in
Helicobacter pylori infected antral mucosa. Gut 35:615–6181994.
28. Domschke S, Bloom SR, Adrian TE, Lux G, Bryant MG, Domschke W. Gastroduodenal mucosal hormone content in duodenal ulcer disease. Hepatogastroenterol 32:198–2011985.
29. Ito H, Tahara E. Immunohistochemical study on G and D cells in the human resected stomach with peptic ulcer disease. In: Miyoshi A, ed. Gut Peptide and Ulcer. Biomedical Research Foundation, Tokyo: 180–1871982.
33. Wu SV, Giraud A, Mogard M, Sumii K, Walsh JH. Effects of inhibition of gastric secretion on antral gastrin and somatostatin gene expression in rats. Am J Physiol 258:G788–7931990.
34. Wu SV, Sumii K, Tari A, Mogard M, Walsh JH. Regulation of gastric soamtostatin gene expression. Metabolism 9:125–1301990.
35. Graham DY, Lew GM, Lechago J. Antral G-cell and D-cell in
Helicobacter pylori infection: effect of
H. pylori eradication. Gastroenterol 104:1655–16601993.
36. Kramling HJ, Enders G, Teichmann RK, Demmel T, Merkle R, Brendel W. Antigen-induced gastrin release: An immunologic mechanism of gastric antral mucosa. Adv Exp Med Biol 216A:427–4291987.
37. Golodner EH, Territo MC, Walsh JH, Soil AH. Stimulation of gastrin release from cultured canine G cells by Helicobacter pylori and mononuclear cells. Gastroenterol 102:A630. 1992.
38. Weigert N, Schaffer K, Schusdziarra V, Classen M, Schepp W. Gastrin secretion from primary cultures of rabbit antral G cells: stimulation by inflammatory cytokines. Gastroenterol 110:147–1541996.